Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Deprescribing: The long road off antidepressants
- Tennessee health firm settles false claims case for $2.4 million
- Pearl River County School District opens fitness trail
- XXL Nutrition’s innovative Protein Soup in collaboration with HAK
- Ask Dr. Nandi: Back-to-school common illnesses, when to keep kids home sick
- D&D Pharmatech to Unveil Muscle-Sparing Obesity Drug Data at U.S. Meeting
- I’m A Lifestyle Writer – 5 Health Habits Research Actually Made Me Change
- Are Media Names Nicole Waudby Homes and Lifestyle GM
Browsing: Wellness Tips
GLP-1 drugs linked to significantly higher risk of hair loss – Earth.com 08-10-2026
Minn. (Northern News Now) – Decades of progress in reducing heart disease deaths are being reversed, driven by rising rates of obesity, high blood sugar and physical inactivity a cardiologist and lead author of a new study examining the trend
KINGSPORT — Dr. Carli Cooper has joined Ballad Health Medical Associates Comprehensive Weight Management Center – Kingsport, according to a Friday press release. The physician will specialize in obesity medicine at the facility, which is a department of Indian Path Community Hospital. Among other care options, her services include anti-obesity medication management, diabetes care and nutritional assessment…
A temporary federal program is helping more South Dakotans gain access to GLP-1 medications to treat obesity. Beginning in July, eligible Medicare Part D beneficiaries pay a fixed rate of $50 per month. It’s a pilot program set to end in December 2027
The recent increasing adoption of GLP-1 drugs has fundamentally changed the landscape of weight loss and health habits. Prescription medicines such as Ozempic, Wegovy, and Mounjaro
Neurocrine Biosciences (NBIX) has drawn fresh attention after announcing a Phase 1 first in human study of NBIP 1968, a triple agonist candidate aimed at obesity treatment and intended for once weekly subcutaneous dosing
Top doctors call for junk food advertising ban, seek curbs on celebrity endorsements and sports sponsorships HomeLive TV Sections WorldEntertainmentExplainersCricketSportsOpinionIndiaTechAutoLifestyleHealthBusinessVideosImpact ShortsWeb Stories Shows VantageFirstpost AmericaFirstpost AfricaFirst SportsSpotlightLive TV Events FIFA World CupUnion BudgetIndependence DayDelhi Elections 2025
The British medicines regulator has approved Eli Lilly’s Foundayo pill, marking a first in Europe for weight management and type 2 diabetes treatment
Standing at 6-foot-6, 288 pounds according to the team’s official 2026 roster, Florida freshman Heze Kent presents the Gators with one of the more unique tight end builds in college football
A daily weight-loss pill made by the drug firm behind the Mounjaro jab has been approved for use in the UK – the first country in Europe to do so

